⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockNetherlandsBrussels

ARGX.BR

argenx SE

Healthcare · Biotechnology

865.20EUR

-0.6000 (-0.07%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxEUR / 865.20
P/E31.4
Dvd Ind Yld—
P/B6.39
P/S10.3
Curr EV/T12M EBITDA—
Mkt Cap (EUR)53.8B
Curr EV (EUR)—
2)

Per Share Data

EPS T12M19.57
DPS—
Bk Val Per Sh115.89
Rev/Sh78.78
Cash/Sh82.89
Curr Shares Out62.2M
FCF/Sh8.64
3)

Cash Flow Analysis

P/CF78.5
Curr P/FCF93.8
CF/NI0.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales13.1%
Eff Interest Rate8.1%
4)

Growth Potential

Dil EPS 1Y Gr53.1%
Cap 1Y Gr33.2%
BPS 1Y Gr31.5%
R&D To Sales31.7%
Retention Rate100.0%
Rev 1Y Gr89.6%
FCF 1Y Gr479.7%
Assets 1Y Gr40.0%
5)

Profitability

EBITDA1.1B
EBIT1.6B
Operating Margin30.6%
Pretax Margin33.4%
Net Margin32.8%
ROA23.5%
ROE27.4%
ROC18.5%
Asset Turnover0.72
6)

Structure

Current Ratio5.12
Quick Ratio4.52
Debt/Assets0.5%
Debt/Com Eq0.6%
Net Debt/EBITDA-3.27
Tot Debt/Capital0.6%
Gross Margin90.0%
EBIT/Int Exp418.1

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years. This company reports in a different currency from the one its shares trade in, so any ratio dividing a market value by a statement figure crosses that boundary un-converted.